Abstract

Studies to establish the structure/function relationships of oligomycin sensitivity-conferring protein (OSCP) of mitochondrial ATP synthase were carried out using genetic engineering and biochemical approaches. A full-length cDNA clone encoding OSCP was isolated from a bovine heart cDNA library, and the mature form of OSCP was expressed in Escherichia coli using plasmid expression vector pKP1500. Recombinant OSCP was found to accumulate in the cytoplasmic inclusion bodies, by virtue of which the recombinant protein could be purified to greater than 85% purity by simple low speed centrifugation of cell lysates. Recombinant OSCP was found to be indistinguishable from OSCP isolated from mitochondria with respect to (i) apparent molecular mass on sodium dodecyl sulfate gel electrophoresis, (ii) immunological reactivity to anti-OSCP serum, (iii) biological activity in restoring oligomycin-sensitive ATPase and Pi-ATP exchange activities to OSCP-depleted ATP synthase complexes, and (iv) insensitivity of the biological activity to sulfhydryl-directed alkylating reagents. The amino-terminal sequence of the recombinant protein revealed that the initiating methionine was not removed by E. coli, although that apparently did not affect protein folding or its biological activity. Data on nested deletion mutations starting from the carboxyl terminus in OSCP demonstrated that, in each instance, the mutant form was expressed and the protein product was sequestered in cytoplasmic inclusion bodies, similar to the wild-type form. However, none of the variants, including the one in which only the last 10 residues were deleted, was able to restore cold-stable oligomycin-sensitive ATPase or Pi-ATP exchange activity in OSCP-depleted complexes. Taken together, these data suggest that amino acid residues 181-190 (or some of the residues in this region) in the OSCP sequence may be important for OSCP-F1 interactions.

Highlights

  • From the $Department of Cell and Molecular Biology, Boston BiomedicalResearch Institute, Boston, Massachusetts 02114, the §Department of Biological Chemistry and Molecular Pharmacology,Harvard Medical School, Boston,Massachusetts 02115, the

  • Recombinant oligomycin sensitivity-conferringprotein (OSCP) was found to accumulate in the cytoplasmic inclusionbodies, byvirtue of which the recombinant protein could be purified to >85% purity by ATP synthase (Fo-F1,H'-ATPase) is a multisubunit membrane-bound enzyme that catalyzes the synthesis of ATP by utilizing the energy of an electrochemical gradient (AFH') that is generated during electrontransport

  • We report on establishing a heterologous expression system in E. coli to synthesize the wild-type protein or native OSCP

Read more

Summary

ATP hydrolyzed

Our data demonstrate that the ATPase activity of complexes reconstituted with deletion mutants of OSCP was not stable to low temperature, unlike that of the complexes reconstituted with the wild-type form. Taken together, these data suggest an impairment inthe binding of OSCP to F1due to truncations in OSCP. Since deletion of residues 181-190 itself leads to inactivation of OSCP, it is not possible to assess the role of residues 151-180 from theseexperiments It is clear, that amino acids residues 181-190 inthe OSCP sequence (or some of the residues in thissegment) are crucial for OSCP-F1 interactions

DISCUSSION
Findings
EXPERIMWTAL PROCEDURES
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call